Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-045808

Director acquired 339 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Salter Malcolm Director 2021-07-02 Grant or award +339 $39.72 $13,465 15,182 D
Loading xslF345X03/doc4.xml…